Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antibiotics > Cefotaxime for Sale > Factory Direct Supply - API for Veterinary Drug - Cefotaxime Sodium - CAS No. 63527-52-6 86%
Factory Direct Supply - API for Veterinary Drug - Cefotaxime Sodium - CAS No. 63527-52-6 86% buy - large image1
Factory Direct Supply - API for Veterinary Drug - Cefotaxime Sodium - CAS No. 63527-52-6 86% buy - image1

Factory Direct Supply - API for Veterinary Drug - Cefotaxime Sodium - CAS No. 63527-52-6 86%

GMP 1 Inquiries

Unit Price: Get Latest Price
CAS No.:

63527-52-6

Grade:

Pharmaceutical Grade

Content:

86%

Packaging:

Drum

Price valid (until):

2022-06-30

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Carbasalate Calcium,Cefotaxime Sodium,Sulfamonomethoxine Sodium,Sulfamonomethoxine

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    The chemical formula of cefotaxime is C16H17N5O7S2, CAS number: 63527-52-6, white powder.
    Uses: Semi-synthetic oxime cephalosporin, the third generation cephalosporin. This product has a strong effect on Gram-negative bacteria, especially Enterobacteriaceae. Mainly used for respiratory system infections, urinary system infections, biliary tract and intestinal infections, skin and soft tissue infections, burns and bone and joint infections caused by sensitive bacteria.
    Indications: For the infection of the respiratory tract, urinary tract, bones and joints, skin and soft tissue, abdominal cavity, biliary tract, digestive tract, facial features, genitals and other parts caused by sensitive bacteria, and for infections caused by burns and trauma, as well as sepsis and central infections also works.

    Certificates

    Basic Info
    Product Name:

    Cefotaxime

    Other Name:

    5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,[6R-[6α,7β(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,(6R,7R)-;(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefotaxime;Claforan;Cephotaxime;Cefotaxime acid;Cefabol;Zeefotax;Ceftax;Omnatax;Taxim;C-Tax;Betaksim;Hexime

    CAS No.:

    63527-52-6

    Molecular Formula:

    C16H17N5O7S2

    InChIKeys:

    InChIKey=GPRBEKHLDVQUJE-QSWIMTSFSA-N

    Molecular Weight:

    455.46548

    Exact Mass:

    455.47

    EC Number:

    264-299-1

    DSSTox ID:

    DTXSID6022761

    HScode:

    29419000

    Categories:

    Antibiotics

    Characteristics
    PSA:

    227.05000

    XLogP3:

    1.20

    Appearance:

    white power

    Density:

    1.8±0.1 g/cm3

    Refractive Index:

    1.779

    Hazard Identification

    Classification of the substance or mixture

    Skin sensitization, Category 1

    Respiratory sensitization, Category 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H317 May cause an allergic skin reaction

    H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled

    Precautionary statement(s)
    Prevention

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P272 Contaminated work clothing should not be allowed out of the workplace.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P284 [In case of inadequate ventilation] wear respiratory protection.

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P333+P317 If skin irritation or rash occurs: Get medical help.

    P321 Specific treatment (see ... on this label).

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    P342+P316 If experiencing respiratory symptoms: Get emergency medical help immediately.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Carbasalate Calcium,Cefotaxime Sodium,Sulfamonomethoxine Sodium,Sulfamonomethoxine

    Location:

    Yuanbaoshan Industrial Zone, Chifeng City, Inner Mongolia, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    45

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    101-200

    Year of Establishment:

    2019

    Company Profile

    Inner Mongolia Yongbang Pharmaceutical Co., Ltd., established in August 2019 with a registered capital of 30 million RMB, is a high-tech enterprise focusing on R&D, production and sale of veterinary APIs.

    The company is located in Yuanbaoshan Industrial Zone, Chifeng City, Inner Mongolia Autonomous Region, built on a total land size of 66,667 square meters. The project is scheduled for two stages with total investment for stage one being 105 million RMB for which it was completed and put into operation in May 2021. The construction for stage one development included an office building, 2 production workshops, 2 warehouses, waste-water treatment facility and other supporting systems. With stage one workshops being fully operational, the company can achieve an annual turnover of 280 million RMB, whilst at the same time providing employment opportunities for more than 100 people. 

    The next stage development planning is well under way with the company looking to start Stage two in May 2023 and investing a further 145 million RMB in building five more production workshops and supporting facilities. With the completion of stage two, the company’s annual turnover is expected to reach 780 million RMB, with further employment opportunities for around 360 people.

    The company strictly adheres to both the international industrial standards and to the national policies and guidelines, while recognising and applying the use of our own strength and capacity to effectively grow into a dynamic and globally recognised manufacturer for veterinary APIs. We also aim to promote the development of China's veterinary API industry and to promote the development of large-scale and standardized veterinary API production. As a manufacturer of veterinary drug raw materials, the company will also devote a vast amount of emphasis on R&D in order to improve our current products and to create more varieties of vet medicine ingredients. 


  • Inquiry History
    1 Inquiries
    Country Product Purchase Quantity Date Posted
    Malaysia

    cefotaxime

    100 G Apr 1, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.